Successful Settlement with HHS-OIG on Behalf of a Private Equity Backed Portfolio Provider

We successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to the Department of Health and Human Services Office of Inspector General (HHS-OIG) involving improper billing. Our team conducted an internal investigation into possible compliance issues, drafted the disclosure to HHS-OIG, and negotiated the final settlement between the parties resulting in a favorable resolution.

You Also May Be Interested In:

Pharos Capital’s Charter Health Acquires St. Luke’s Home Hospice LLC and Arizona Select Hospice LLC

We represented Pharos Capital’s post-acute care provider platform, Charter Health Care Group, in its acquisition of two hospice service providers,...

Client Type: Private Company
Representation of Life Sciences Company Fagron Holding USA LLC

Representation of Life Sciences Company Fagron Holding USA LLC

We served as lead counsel representing a national pharmaceutical ingredient supplier and its wholly-owned subsidiaries in an investigation of alleged...

Client Type: Private Company
axialHealthcare Closes Series C Funding Round

Representation of axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15 million Series C round of financing to accelerate its expansion into the substance use disorder (SUD) treatment, and recovery sector. Previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund led the round.

We represented axialHealthcare, a care optimization platform navigating substance use issues for patients, providers, and health plans, in a $15...

Client Type: Private Company